SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-001021
Filing Date
2019-09-04
Accepted
2019-09-04 07:06:33
Documents
49
Period of Report
2019-09-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv528746_8k.htm   iXBRL 8-K 25350
2 EXHIBIT 99.1 tv528746_ex99-1.htm EX-99.1 50574
6 GRAPHIC tv528746_ex99-1img001.jpg GRAPHIC 294896
7 GRAPHIC tv528746_ex99-1img002.jpg GRAPHIC 465712
8 GRAPHIC tv528746_ex99-1img003.jpg GRAPHIC 393710
9 GRAPHIC tv528746_ex99-1img004.jpg GRAPHIC 314539
10 GRAPHIC tv528746_ex99-1img005.jpg GRAPHIC 270661
11 GRAPHIC tv528746_ex99-1img006.jpg GRAPHIC 324548
12 GRAPHIC tv528746_ex99-1img007.jpg GRAPHIC 368222
13 GRAPHIC tv528746_ex99-1img008.jpg GRAPHIC 324946
14 GRAPHIC tv528746_ex99-1img009.jpg GRAPHIC 330243
15 GRAPHIC tv528746_ex99-1img010.jpg GRAPHIC 304817
16 GRAPHIC tv528746_ex99-1img011.jpg GRAPHIC 319224
17 GRAPHIC tv528746_ex99-1img012.jpg GRAPHIC 294432
18 GRAPHIC tv528746_ex99-1img013.jpg GRAPHIC 433257
19 GRAPHIC tv528746_ex99-1img014.jpg GRAPHIC 328442
20 GRAPHIC tv528746_ex99-1img015.jpg GRAPHIC 310831
21 GRAPHIC tv528746_ex99-1img016.jpg GRAPHIC 293212
22 GRAPHIC tv528746_ex99-1img017.jpg GRAPHIC 322088
23 GRAPHIC tv528746_ex99-1img018.jpg GRAPHIC 283652
24 GRAPHIC tv528746_ex99-1img019.jpg GRAPHIC 321241
25 GRAPHIC tv528746_ex99-1img020.jpg GRAPHIC 262655
26 GRAPHIC tv528746_ex99-1img021.jpg GRAPHIC 337044
27 GRAPHIC tv528746_ex99-1img022.jpg GRAPHIC 395377
28 GRAPHIC tv528746_ex99-1img023.jpg GRAPHIC 302229
29 GRAPHIC tv528746_ex99-1img024.jpg GRAPHIC 277294
30 GRAPHIC tv528746_ex99-1img025.jpg GRAPHIC 333414
31 GRAPHIC tv528746_ex99-1img026.jpg GRAPHIC 319438
32 GRAPHIC tv528746_ex99-1img027.jpg GRAPHIC 321318
33 GRAPHIC tv528746_ex99-1img028.jpg GRAPHIC 343374
34 GRAPHIC tv528746_ex99-1img029.jpg GRAPHIC 270964
35 GRAPHIC tv528746_ex99-1img030.jpg GRAPHIC 309432
36 GRAPHIC tv528746_ex99-1img031.jpg GRAPHIC 297920
37 GRAPHIC tv528746_ex99-1img032.jpg GRAPHIC 287598
38 GRAPHIC tv528746_ex99-1img033.jpg GRAPHIC 296101
39 GRAPHIC tv528746_ex99-1img034.jpg GRAPHIC 334742
40 GRAPHIC tv528746_ex99-1img035.jpg GRAPHIC 246124
41 GRAPHIC tv528746_ex99-1img036.jpg GRAPHIC 366704
  Complete submission text file 0001410578-19-001021.txt   16241933

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tbph-20190904.xsd EX-101.SCH 3193
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20190904_lab.xml EX-101.LAB 33476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20190904_pre.xml EX-101.PRE 21963
46 EXTRACTED XBRL INSTANCE DOCUMENT tv528746_8k_htm.xml XML 3625
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 191073296
SIC: 2834 Pharmaceutical Preparations